These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38802092)

  • 1. Moving forward. Use of the START NOW skills training program for female youth with ODD and CD - a commentary on Stadler et al. (2024).
    Tripp G
    J Child Psychol Psychiatry; 2024 May; ():. PubMed ID: 38802092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. START NOW - a comprehensive skills training programme for female adolescents with oppositional defiant and conduct disorders: study protocol for a cluster-randomised controlled trial.
    Kersten L; Prätzlich M; Mannstadt S; Ackermann K; Kohls G; Oldenhof H; Saure D; Krieger K; Herpertz-Dahlmann B; Popma A; Freitag CM; Trestman RL; Stadler C
    Trials; 2016 Dec; 17(1):568. PubMed ID: 27903282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. START NOW: a cognitive behavioral skills training for adolescent girls with conduct or oppositional defiant disorder - a randomized clinical trial.
    Stadler C; Freitag CM; Popma A; Nauta-Jansen L; Konrad K; Unternaehrer E; Ackermann K; Bernhard A; Martinelli A; Oldenhof H; Gundlach M; Kohls G; Prätzlich M; Kieser M; Limprecht R; Raschle NM; Vriends N; Trestman RL; Kirchner M; Kersten L
    J Child Psychol Psychiatry; 2024 Mar; 65(3):316-327. PubMed ID: 37814906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mentalization-based treatment for adolescents with conduct disorder (MBT-CD): protocol of a feasibility and pilot study.
    Taubner S; Hauschild S; Kasper L; Kaess M; Sobanski E; Gablonski TC; Schröder-Pfeifer P; Volkert J
    Pilot Feasibility Stud; 2021 Jul; 7(1):139. PubMed ID: 34215323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive functioning and emotion recognition in youth with oppositional defiant disorder and/or conduct disorder.
    Kleine Deters R; Naaijen J; Rosa M; Aggensteiner PM; Banaschewski T; Saam MC; Schulze UME; Sethi A; Craig MC; Sagar-Ouriaghli I; Santosh P; Castro-Fornieles J; Penzol MJ; Arango C; Werhahn JE; Brandeis D; Franke B; Glennon J; Buitelaar JK; Hoekstra PJ; Dietrich A
    World J Biol Psychiatry; 2020 Sep; 21(7):539-551. PubMed ID: 32212964
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom Profiles of CD and ODD Among Youth With Perinatally Acquired HIV.
    Osigwe I; Gadow KD; Nachman S; Drabick DAG
    J Pediatr Psychol; 2020 Jan; 45(1):72-80. PubMed ID: 31599943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental pathways in oppositional defiant disorder and conduct disorder.
    Rowe R; Costello EJ; Angold A; Copeland WE; Maughan B
    J Abnorm Psychol; 2010 Nov; 119(4):726-38. PubMed ID: 21090876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships and Continuities in Symptoms of Oppositional Defiant and Conduct Disorders from Age 4 to 10 in the Community.
    Husby SM; Wichstrøm L
    J Abnorm Child Psychol; 2017 Jul; 45(5):947-958. PubMed ID: 27783258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of a school-based prevention and early intervention program to reduce oppositional defiant disorder/conduct disorder.
    Winther J; Carlsson A; Vance A
    Early Interv Psychiatry; 2014 May; 8(2):181-9. PubMed ID: 23734628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which better predicts conduct problems? The relationship of trajectories of conduct problems with ODD and ADHD symptoms from childhood into adolescence.
    van Lier PA; van der Ende J; Koot HM; Verhulst FC
    J Child Psychol Psychiatry; 2007 Jun; 48(6):601-8. PubMed ID: 17537076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered brain morphology in boys with attention deficit hyperactivity disorder with and without comorbid conduct disorder/oppositional defiant disorder.
    Vetter NC; Backhausen LL; Buse J; Roessner V; Smolka MN
    Hum Brain Mapp; 2020 Mar; 41(4):973-983. PubMed ID: 31691449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Versus Specific Correlates of Fifth-Grade Conduct Disorder and Oppositional Defiant Disorder Symptoms: Comparison of Three Racial/Ethnic Groups.
    Wiesner M; Elliott MN; McLaughlin KA; Banspach SW; Tortolero S; Schuster MA
    J Abnorm Child Psychol; 2015 Jul; 43(5):985-98. PubMed ID: 25411125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bottom-up and top-down approaches to understanding oppositional defiant disorder symptoms during early childhood: a mixed method study.
    Ljungström BM; Kenne Sarenmalm E; Axberg U
    Child Adolesc Psychiatry Ment Health; 2020; 14():34. PubMed ID: 32944068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of oppositional defiant disorder dimensions on the temporal ordering of conduct problems and depression across childhood and adolescence in girls.
    Hipwell AE; Stepp S; Feng X; Burke J; Battista DR; Loeber R; Keenan K
    J Child Psychol Psychiatry; 2011 Oct; 52(10):1099-108. PubMed ID: 21815894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy risk factors in relation to oppositional-defiant and conduct disorder symptoms in the Avon Longitudinal Study of Parents and Children.
    Ruisch IH; Buitelaar JK; Glennon JC; Hoekstra PJ; Dietrich A
    J Psychiatr Res; 2018 Jun; 101():63-71. PubMed ID: 29550610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive validity of childhood oppositional defiant disorder and conduct disorder: implications for the DSM-V.
    Burke JD; Waldman I; Lahey BB
    J Abnorm Psychol; 2010 Nov; 119(4):739-51. PubMed ID: 20853919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.